Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Addiction. 2015 Nov 11;111(3):535–544. doi: 10.1111/add.13183

TABLE 4.

Nicotine pharmacokinetic profiles from various electronic cigarettes

Subject Half-life (min) Tmax (min) Cmax (ng/mL) AUC(0→∞) (ng/mL•min) Delivered nicotine dose (mg) Retained nicotine dose (mg) PK-estimated nicotine dose (mg)
1 148 2 6.9 815 0.84 0.84 0.98
2 81 5 9.1 1345 1.64 1.63 1.61
3 87 30 2.3 301 1.66 0.82 0.36
4 152 5 8.9 1570 2.64 2.34 1.88
5 62 2 15.5 682 1.33 1.30 0.82
6 94 2 3.1 264 n/a n/a 0.32
7 152 2 19.8 1813 2.43 2.42 2.18
8 132 5 8.7 1336 1.63 1.52 1.60
9 140 5 4.4 461 0.58 0.58 0.55
10 78 2 6.1 332 0.60 0.60 0.40
11 114 2 13.2 900 1.45 1.44 1.08
12 107 2 4.7 411 0.42 0.42 0.49
13 36 2 6.8 721 0.70 0.69 0.87

Average 106.3 5.1 8.4 843 1.33 1.22 1.01
Median 107 2 5.1 721 1.39 1.07 0.87
SD 37.2 7.6 5.1 519 0.73 0.68 0.62
LCI 84 0.5 5.4 529 0.87 0.80 0.63
UCI 129 9.7 11.5 1156 1.79 1.66 1.39

Notes: SD, standard deviation; LCI and UCI, lower and upper limits of 95% confidence interval; PK-estimated nicotine dose is average population clearance of nicotine (~1200 mL/min) × AUC(0–∞)

HHS Vulnerability Disclosure